Skip to content

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03686605
Enrollment
49
Registered
2018-09-27
Start date
2018-09-24
Completion date
2020-01-31
Last updated
2022-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Screening Tool for Depresion in Cancer Pain Patients

Brief summary

Compare Thai versions of the Edmonton Symptom Assessment System (ESAS) and the Hospiral Anxiety and Depression Scale (HADS) with Diagnostic and Statistical Manual (DSM-5), as a screening tool for depression in cancer pain patients

Interventions

OTHERThai version of the Edmontom Symptom Assessment System (ESAS)

Screening and diagnostic questionaire for depression

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Cancer patients who follow up as out patient at pain clinic, Siriraj hospital * Age older than 18 years old * Fluently read, write and speak in Thai language * No cognitive impairment

Exclusion criteria

* Unstable clinical presentation * Severe pain or pain numerical rating scale more than 7 * Severe associated symptoms such as nausea, vomiting * The patient who do not know their diagnosis

Design outcomes

Primary

MeasureTime frameDescription
Reliability and validity of Thai version of ESAS1 yearCut-off point, sensitivity, specificity, positive predictive value and negative predictive value of Thai version of ESAS

Secondary

MeasureTime frameDescription
Correlation of Thai version of ESAS, HADS and DSM-51 yearPearson correlation, Sperman rank correlation
Internal consistency of Thai version of ESAS and HADS1 yearCronbach's alpha

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026